Millennium Pharmacon International (JK:SDPC) — Stock Price

Rp189.00 IDR
▲ 2.72% today

Millennium Pharmacon International (JK:SDPC) is currently trading at Rp189.00 IDR, up 2.72% today. Over the past 52 weeks, shares have ranged between Rp129.00 and Rp202.00. This page tracks Millennium Pharmacon International's live share price on the JK exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see SDPC company net worth.

Millennium Pharmacon International (SDPC) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Millennium Pharmacon International's daily closing share price and trading volume on the JK exchange over the past year, giving a clear view of recent price momentum and liquidity.

Millennium Pharmacon International Income Statement — Revenue, Profit & Earnings by Year

Millennium Pharmacon International's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20242023202220212020
Total Revenue Rp3.92 Trillion Rp3.36 Trillion Rp3.20 Trillion Rp2.99 Trillion Rp2.64 Trillion
Cost of Revenue Rp3.58 Trillion Rp3.07 Trillion Rp2.93 Trillion Rp2.75 Trillion Rp2.42 Trillion
Gross Profit Rp334.38 Billion Rp289.82 Billion Rp269.63 Billion Rp241.75 Billion Rp221.69 Billion
Research & Development — — — — —
SG&A Rp35.32 Billion Rp136.78 Billion Rp32.02 Billion Rp24.73 Billion Rp23.10 Billion
Total Operating Expenses Rp237.94 Billion Rp184.42 Billion Rp185.25 Billion Rp172.92 Billion Rp167.92 Billion
Operating Income Rp96.43 Billion Rp105.40 Billion Rp73.96 Billion Rp57.74 Billion Rp52.77 Billion
EBITDA Rp120.06 Billion Rp124.51 Billion Rp91.48 Billion Rp73.60 Billion Rp69.34 Billion
EBIT Rp96.49 Billion Rp105.54 Billion Rp74.95 Billion Rp57.82 Billion Rp52.77 Billion
Interest Expense Rp68.79 Billion Rp57.58 Billion Rp38.48 Billion Rp39.89 Billion Rp45.12 Billion
Income Before Tax Rp27.70 Billion Rp47.96 Billion Rp36.46 Billion Rp17.92 Billion Rp7.74 Billion
Income Tax Expense Rp10.79 Billion Rp14.88 Billion Rp12.00 Billion Rp8.35 Billion Rp4.94 Billion
Net Income Rp16.91 Billion Rp33.09 Billion Rp24.46 Billion Rp9.57 Billion Rp2.80 Billion

Millennium Pharmacon International Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Millennium Pharmacon International's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20242023202220212020
Total Assets Rp1.77 Trillion Rp1.64 Trillion Rp1.40 Trillion Rp1.21 Trillion Rp1.16 Trillion
Total Current Assets Rp1.56 Trillion Rp1.45 Trillion Rp1.26 Trillion Rp1.07 Trillion Rp1.03 Trillion
Cash & Equivalents — — — — —
Short-term Investments — — — Rp-20.88 Billion Rp-26.47 Billion
Net Receivables Rp741.59 Billion Rp682.83 Billion Rp568.49 Billion Rp461.07 Billion Rp498.76 Billion
Inventory Rp567.73 Billion Rp535.87 Billion Rp538.43 Billion Rp453.30 Billion Rp389.35 Billion
Property, Plant & Equipment Rp111.42 Billion Rp112.59 Billion Rp46.70 Billion Rp42.29 Billion Rp48.14 Billion
Goodwill — — — — —
Total Liabilities Rp1.49 Trillion Rp1.36 Trillion Rp1.14 Trillion Rp969.41 Billion Rp935.63 Billion
Total Current Liabilities Rp1.41 Trillion Rp1.29 Trillion Rp1.11 Trillion Rp942.59 Billion Rp903.26 Billion
Long-term Debt Rp43.31 Billion Rp44.00 Billion Rp0.00 — —
Net Debt Rp793.05 Billion Rp651.44 Billion Rp542.39 Billion Rp409.59 Billion Rp337.36 Billion
Total Stockholder Equity Rp282.52 Billion Rp277.72 Billion Rp258.91 Billion Rp236.98 Billion Rp229.20 Billion
Retained Earnings Rp161.38 Billion Rp151.35 Billion Rp123.15 Billion Rp102.49 Billion Rp95.35 Billion

Millennium Pharmacon International Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Millennium Pharmacon International generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20242023202220212020
Operating Cash Flow Rp-125.45 Billion Rp-91.65 Billion Rp41.00 Billion Rp-18.18 Billion Rp71.69 Billion
Capital Expenditures Rp14.16 Billion Rp21.52 Billion Rp14.68 Billion Rp4.47 Billion Rp3.81 Billion
Free Cash Flow Rp-139.61 Billion Rp-113.17 Billion Rp26.32 Billion Rp-22.65 Billion Rp67.88 Billion
Investing Cash Flow Rp-13.92 Billion Rp-5.52 Billion Rp-14.61 Billion Rp-4.21 Billion Rp-3.81 Billion
Financing Cash Flow Rp133.94 Billion Rp130.40 Billion Rp102.86 Billion Rp21.69 Billion Rp-49.32 Billion
Dividends Paid Rp-3.19 Billion Rp-2.55 Billion Rp-1.27 Billion Rp-637.00 Million Rp1.27 Billion
Stock-Based Compensation — — — — —
Depreciation — Rp18.97 Billion Rp16.53 Billion Rp15.79 Billion Rp15.48 Billion
Change in Cash Rp-5.43 Billion Rp33.23 Billion Rp-21.69 Billion Rp-691.99 Million Rp18.56 Billion

Millennium Pharmacon International Earnings History — EPS Actual vs. Analyst Estimates

Track Millennium Pharmacon International's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
May 30, 2025 — — —
Jun 30, 2023 13.58 — —
Mar 31, 2023 4.59 — —
Sep 30, 2022 7.79 — —
Jun 30, 2022 2.21 — —
Mar 31, 2022 8.72 — —
Dec 31, 2021 -0.35 — —
Sep 30, 2021 5.26 — —